Benchmark analyst Robert Wasserman downgrades Danaher (NYSE:DHR) from Buy to Hold.
What’s Going On With Netherlands-Based Biopharma Company Pharming Shares Today?
Pharming Group (NASDAQ: PHAR) updated its full-year 2023 guidance, including RUCONEST and Joenja revenues, and a progress update on the